Identification of immunodominant epitopes of α-gliadin in HLA-DQ8 transgenic mice following oral immunization

Journal of Immunology

Volumn 175, Issue 12, 2005, Pages 8087-8095

  Senger, Stefania ^a   Maurano, Francesco ^a   Mazzeo, Maria F ^a   Gaita, Marcello ^a   Fierro, Olga ^a   David, Chella S ^b   Troncone, Riccardo ^c   Auricchio, Salvatore ^c   Siciliano, Rosa A ^a   Rossi, Mauro ^a  

^a CNR   (Italy)

^b MAYO GRADUATE SCHOOL   (United States)

^c UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLERA TOXIN; EPITOPE; GLIADIN; HLA DQ2 ANTIGEN; HLA DQ8 ANTIGEN; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BARLEY; CELIAC DISEASE; CONTROLLED STUDY; DEAMINATION; EPITOPE MAPPING; GLUTEN FREE DIET; IMMUNIZATION; IMMUNOGENICITY; IN VITRO STUDY; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN ANALYSIS; RYE; TH2 CELL; WHEAT;

EID: 29144480200     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.175.12.8087     Document Type: Article

References (55)

1. Sette, A., and L. Fikes. 2003. Epitope-based vaccines: an update on epitope identification, vaccine design and delivery. Curr. Opin. Immunol. 15: 461-470.
2. Maki, M., and P. Collin. 1997. Coeliac disease. Lancet 349: 1755-1759.
3. Kagnoff, M. F. 2005. Overview and pathogenesis of celiac disease. Gastroenterology 128: S10-S18.
4. Maiuri, L., C. Ciacci, I. Ricciardelli, L. Vacca, V. Raia, S. Auricchio, J. Picard, M. Osman, S. Quaratino, and M. Londei. 2003. Association between innate response to gliadin and activation of pathogenic T cells in coeliac disease. Lancet 362: 30-37.
5. Vader, L. W., A. de Ru, Y. van der Wal, Y. M. C. Kooy, W. Benckhuijsen, M. L. Merin, J. W. Wouter Drijfhout, P. van Veelen, and F. Koning. 2002. Specificity of tissue transglutaminase explains cereal toxicity in celiac disease. J. Exp. Med. 195: 643-649.
6. Molberg, O., S. N. McAdam, R. Korner, H. Quarsten, C. Kristiansen, L. Madsen. L. Fugger, H. Scott, O. Noren, P. Roepstorff, et al. 1998. Tissue transglutaminase selectively modifies gliadin peptides that are recognized by gut-derived T cells in celiac disease. Nat. Med. 4: 713-717.
7. Arentz-Hansen, H., S. N. McAdam, O. Molberg, B. Fleckenstein, K. E. Lundin, T. J. Jorgensen, G. Jung, P. Roepstorff, and L. M. Sollid. 2002. Celiac lesion T cells recognize epitopes that cluster in regions of gliadins rich in proline residues. Gastroenterology 123: 803-809.
8. Hausch, F., L. Shan, N. A. Santiago, G. M. Gray, and C. Khosla. 2002. Intestinal digestive resistance of immunodominant gliadin peptides. Am. J. Physiol Gastrointest. Liver Physiol. 283: G996-G1003.
9. Vader, W., Y. Kooy, P. Van Veelen, A. De Ru, D. Harris, W. Benckhuijsen, S. Pena, L. Mearin, J. W. Drijfhout, and F. Koning. 2002. The gluten response in children with celiac disease is directed toward multiple gliadin and glutenin peptides. Gastroenterology 122: 1729-1737.
10. Anderson, R. P., P. Degano, A. J. Godkin, D. P. Jewell, and A. V. Hill. 2000. In vivo antigen challenge in celiac disease identifies a single transglutaminase-modified peptide as the dominant A-gliadin T-cell epitope. Nat. Med. 6: 337-342.
11. Shan, L., O. Molberg, I. Parrot, F. Hausch, F. Filiz, G. M. Gray, L. M. Sollid, and C. Khosla. 2002. Structural basis for gluten intolerance in celiac sprue. Science 297: 2275-2279.
12. Van de Wal, Y., Y. M. Kooy, P. A. van Veelen, S. A. Pena, L. M. Mearin, O. Molberg, K. E. Lundin, L. M. Sollid, T. Mutis, W. E. Benckhuijsen, et al. 1998. Small intestinal T cells of celiac disease patients recognize a natural pepsin fragment of gliadin. Proc. Natl. Acad. Sci. USA 95: 10050-10054.
13. Mazzarella, G., M. Maglio, F. Paparo, G. Nardone, R. Stefanile, L. Greco, Y. van de Wal, Y. Kooy, F. Koning, S. Auricchio, and R. Troncone. 2003. An immunodominant DQ8 restricted gliadin peptide activates small intestinal immune response in in vitro cultured mucosa from HLA-DQ8 positive but not HLA-DQ8 negative coeliac patients. Gut 52: 57-62.
14. Abraham, R. S., and C. S. David. 2000. Identification of HLA-class-II-restricted epitopes of autoantigens in transgenic mice. Curr. Opin. Immunol. 12: 122-129.
15. Black, K. E., J. A. Murray, and C. S. David. 2002. HLA-DQ determines the response to exogenous wheat proteins: a model of gluten sensitivity in transgenic knockout mice. J. Immunol. 169: 5595-5600.
16. Marietta, E., K. Black, M. Camilleri, P. Krause, R. S. Rogers III, C. David, M. R. Pittelkow, and J. A. Murray. 2004. A new model for dermatitis herpetiformis that uses HLA-DQ8 transgenic NOD mice. J. Clin. Invest. 114: 1090-1097.
17. Cheng, S., J. Baisch, C. Krco, S. Savarirayan, J. Hanson, K. Hodgson, M. Smart, and C. David. 1996. Expression and function of HLA-DQ8 (DQA1*0301/DQB1*0302) genes in transgenic mice. Eur. J. Immunogenet. 23: 15-20.
18. Kasarda, D. D., and R. D'Ovidio. 1999. Deduced amino acid sequence of an α gliadin gene from spelt wheat (Spelta) includes sequences active in celiac disease. Cereal. Chem. 76: 548-551.
19. Arentz-Hansen, E. H., S. N. McAdam, O. Molberg, C. Kristiansen, and L. M. Sollid. 2000. Production of a panel of recombinant gliadins for the characterization of T cell reactivity in coeliac disease. Gut 46: 46-51.
20. Maurano, F., R. A. Siciliano, B. De Giulio, D. Luongo, M. F. Mazzeo, R. Troncone, S. Auricchio, and M. Rossi. 2001. Intranasal administration of one α gliadin can down-regulate the immune response to whole gliadin in mice. Scand. J. Immunol. 53: 290-295.
21. Plan, S. G., and D. D. Kasarda. 1971. Separation and characterization of gliadin fractions. Biochim. Biophys. Acta 243: 407-415.
22. Kagnoff, M. F., R. K. Austin, H. C. L. Johnson, J. E. Bernardin, M. D. Dietler, and D. D. Kasarda. 1982. Coeliac sprue: correlation with murine T cell responses to wheat gliadin components. J. Immunol. 129: 2693-2697.
23. Mazzeo, M. F., B. De Giulio, S. Senger, M. Rossi, A. Malorni, and R. A. Siciliano. 2003. Identification of transglutaminase-mediated deamidation sites in a recombinant α-gliadin by advanced mass-spectrometric methodologies. Protein Sci. 12: 2434-2442.
24. + T cell responses: identification of a novel gliadin-derived HLA-A2-restricted epitope. J. Immunol. 170: 2719-2726.
25. Kwok, W. W., G. T. Nepom, and F. C. Raymond. 1995. HLA-DQ polymorphisms are highly selective for peptide binding interactions. J. Immunol. 155: 2468-2476.
26. Lee, K. H., K. W. Wucherpfennig, and D. C. Wiley. 2001. Structure of a human insulin peptide-HLA-DQ8 complex and susceptibility to type 1 diabetes. Nat. Immunol. 2: 501-507.
27. Moustakas, A. K., Y. van de Wal, J. Routsias, Y. M. Kooy, P. van Veelen, J. W. Drijfhout, F. Koning, and G. K. Papadopoulos. 2000. Structure of celiac disease-associated HLA-DQ8 and non-associated HLA-DQ9 alleles in complex with two disease-specific epitopes. Int. Immunol. 12: 1157-1166.
28. Trier, J. S. 1991. Celiac sprue. W. Engl. J. Med. 325: 1709-1719.
29. Wieser, H., A. Mödl, W. Seilmeier, and H. D. Belitz. 1987. High-performance liquid chromatography of gliadins from different wheat varieties: amino acid composition and N-terminal amino acid sequence of components. Z. Lebens. Unters. Forsch. 185: 371-378.
30. De Ritis, G., S. Auricchio, H. W. Jones, E. J. Lew, J. E. Bernardin, and D. D. Kasarda. 1988. In vitro (organ culture) studies of the toxicity of specific A-gliadin peptides in celiac disease. Gastroenterology 94: 41-49.
31. Sturgess, R., P. Day, H. J. Ellis, K. E. Lundin, H. A. Gjertsen, M. Kontakou, and P. J. Ciclitira. 1994. Wheat peptide challenge in coeliac disease. Lancet 343: 758-761.
32. Arentz-Hansen, H., R. Korner, O. Molberg, H. Quarsten, W. Vader, Y. M. Kooy, K. E. Lundin, F. Koning, P. Roepstorff, L. M. Sollid, and S. N. McAdam. 2000. The intestinal T cell response to α-gliadin in adult celiac disease is focused on a single deamidated glutamine targeted by tissue transglutaminase. J. Exp. Med. 191: 603-612.
33. Senger, S., D. Luongo, F. Maurano, M. F. Mazzeo, R. A. Siciliano, C. Gianfrani, C. David, R. Troncone, S. Auricchio, and M. Rossi. 2003. Intranasal administration of a recombinant α-gliadin down-regulates the immune response to wheat gliadin in DQ8 transgenic mice. Immunol. Lett. 88: 127-134.
34. Geluk, A., V. Taneja, K. E. van Meijgaarden, E. Zanelli, C. Abou-Zeid, J. E. Thole, R. R. de Vries, C. S. David, and T. H. Ottenhoff. 1998. Identification of HLA class II-restricted determinants of Mycobacterium tuberculosis-derived proteins by using HLA-transgenic, class II-deficient mice. Proc. Natl. Acad. Sci. USA 95: 10797-10802.
35. Khare, M., M. Rodriguez, and C. S. David. 2003. HLA class II transgenic mice authenticate restriction of myelin oligodendrocyte glycoprotein-specific immune response implicated in multiple sclerosis pathogenesis. Int. Immunol. 15: 535-546.
36. + T cell epitopes in a nested configuration and elicits both T cell subset responses by peptide or DNA immunization. Cell. Immunol. 205: 73-83.
37. + class II-restricted cytotoxic T lymphocytes are contained within an influenza nucleoprotein peptide. J. Immunol. 148: 894-899.
38. Van de Wal, Y., Y. M. Kooy, J. W. Drijfhout, R. Amons, and F. Koning. 1996. Peptide binding characteristics of the coeliac disease-associated DQ(α1*0501. β1*0201) molecule. Immunogenetics 44: 246-253.
39. Sollid, L. M. 2000. Molecular basis of celiac disease. Annu. Rev. Immunol. 18: 53-81.
40. Qiao, S. W., J. Piper, G. Haraldsen, I. Oynebraten, B. Fleckenstein, O. Molberg, C. Khosla, and L. M. Sollid. 2005. Tissue transglutaminase-mediated formation and cleavage of histamine-gliadin complexes: biological effects and implications for celiac disease. J. Immunol. 174: 1657-1663.
41. Gjertsen, H. A., K. E. Lundin, L. M. Sollid, J. A. Eriksen, and E. Thorsby. 1994. T cells recognize a peptide derived from α-gliadin presented by the celiac disease-associated HLA-DQ (α1*0501. β1*0201) heterodimer. Hum. Immunol. 39: 243-252.
42. Godkin, A. J., M. P. Davenport, A. Willis, D. P. Jewell, and A. V. Hill. 1998. Use of complete eluted peptide sequence data from HLA-DR and -DQ molecules to predict T cell epitopes, and the influence of the nonbinding terminal regions of ligands in epitope selection. J. Immunol. 161: 850-858.
43. Godkin, A., T. Friede, M. Davenport, S. Stevanovic, A. Willis, D. Jewell, A. Hill, and H. G. Rammensee. 1997. Use of eluted peptide sequence data to identify the binding characteristics of peptides to the insulin-dependent diabetes susceptibility allele HLA-DQ8 (DQ 3.2). Int. Immunol. 9: 905-911.
44. Kwok, W. W., M. L. Domeier, F. C. Raymond, P. Byers, and G. T. Nepom. 1996. Allele-specific motifs characterize HLA-DQ interactions with a diabetes-associated peptide derived from glutamic acid decarboxylase. J. Immunol. 156: 2171-2177.
45. Marinaro, M., H. F. Staats, T. Hiroi, R. J. Jackson, M. Coste, P. N. Boyaka, N. Okahashi, M. Yamamoto, H. Kiyono, H. Bluethmann, et al. 1995. Mucosal adjuvant effect of cholera toxin in mice results from induction of T helper 2 (Th2) cells and IL-4. J. Immunol. 5: 4621-4629.
46. Lavelle, E. C., E. McNeela, M. E. Armstrong, O. Leavy, S. C. Higgins, and K. H. Mills. 2003. Cholera toxin promotes the induction of regulatory T cells specific for bystander antigens by modulating dendritic cell activation. J. Immunol. 171: 2384-2392.
47. Nilsen, E. M., F. L. Jahnsen, K. E. Lundin, F. E. Johansen, O. Fausa, L. M. Sollid, J. Jahnsen, H. Scott, and P. Brandtzaeg. 1998. Gluten induces an intestinal cytokine response strongly dominated by interferon γ in patients with celiac disease. Gastroenterology 115: 551-563.
48. McMahon, E. J., S. L. Bailey, C. V. Castenada, H. Waldner, and S. D. Miller. 2005. Epitope spreading initiates in the CNS in two mouse models of multiple sclerosis. Nat. Med. 11: 335-339.
49. Klehmet, J., C. Shive, R. Guardia-Wolff, I. Petersen, E. G. Spack, B. O. Boehm, R. Weissert, and T. G. Forsthuber. 2004. T cell epitope spreading to myelin oligodendrocyte glycoprotein in HLA-DR4 transgenic mice during experimental autoimmune encephalomyelitis. Clin. Immunol. 111: 53-60.
50. McRae, B. L., C. L. Vanderlugt, M. C. Dal Canto, and S. D. Miller. 1995. Functional evidence for epitope spreading in the relapsing pathology of experimental autoimmune encephalomyelitis. J. Exp. Med. 182: 75-85.
51. Ott, P. A., M. T. Dittrich, B. A. Herzog, R. Guerkov, P. A. Gottlieb, A. L. Putnam, I. Durinovic-Bello, B. O. Boehm, M. Tary-Lehmann, and P. V. Lehmann. 2004. T cells recognize multiple GAD65 and proinsulin epitopes in human type 1 diabetes, suggesting determinant spreading. J. Clin. Immunol. 24: 327-339.
52. Veeraraghavan, S., E. A. Renzoni, H. Jeal, M. Jones, J. Hammer, A. U. Wells, C. M. Black, K. I. Welsh, and R. M. du Bois. 2004. Mapping of the immunodominant T cell epitopes of the protein topoisomerase I. Ann. Rheum. Dis. 63: 982-987.
53. Zuercher, A. W., S. E. Coffin, M. C. Thurnheer, P. Fundova, and J. J. Cebra. 2002. Nasal-associated lymphoid tissue is a mucosal inductive site for virus-specific humoral and cellular immune responses. J. Immunol. 168: 1796-1803.
54. Prakken, B. J., R. van der Zee, S. M. Anderton, P. J. van Kooten, W. Kuis, and W. van Eden. 1997. Peptide-induced nasal tolerance for a mycobacterial heat shock protein 60 T cell epitope in rats suppresses both adjuvant arthritis and nonmicrobially induced experimental arthritis. Proc. Natl. Acad. Sci. USA 94: 3284-3289.
55. Rossi, M., F. Maurano, N. Caputo, S. Auricchio, A. Sette, R. Capparelli, and R. Troncone. 1999. Intravenous or intranasal administration of gliadin is able to down-regulate the specific immune response in mice. Scand. J. Immunol. 50: 177-182.